Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • August 2021 •
  • 144 pages •
  • Report ID: 5917272 •
  • Format: PDF
The global array instruments market exhibited moderate growth during 2015-2020.

Looking forward, the analyst expects the market to grow at a CAGR of 5.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

An array instrument is used in laboratories for quantitatively and simultaneously monitoring the expression of multiple genes. It contains numerous small representative tissue samples from hundreds of different cases, which are assembled on a single histologic slide. The high-throughput approach of the array instrument aids in locating chromosomal expressions and mutations in a genotype, as well as measuring and detecting gene expressions at the messenger RNA (mRNA) or protein level. As a result, it finds applications in molecular and cell biology, genetics, molecular pathology, and for synthesizing and sequencing nucleic acids.

The increasing prevalence of chronic diseases, in confluence with the emerging need for their early detection and diagnosis, represents one of the key factors driving the global array instruments market growth. In addition to this, governments of several countries are investing in the improvement of healthcare facilities, which in turn, is positively influencing the demand for array instruments, especially in emerging economies. Furthermore, these instruments can be incorporated with a wide range of technologies, owing to which they find applications in different areas of research, such as life sciences and drug discovery. For instance, deoxyribonucleic acid (DNA) microarrays are used for examining changes in gene expression by fluorescent labeling of complementary DNA, whereas tissue microarrays aid in identifying new diagnostic and prognostic markers and targeting cancer in human beings. Other than this, the introduction of advanced technologies, such as microarray-based comparative genomic hybridization (array CGH), is expected to bolster the market growth in the upcoming years.

Breakup by Application:
Molecular Biology
Cell Biology
Molecular Pathology

Breakup by Technology:
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays

Breakup by End-User:
Research and Development Laboratories
Clinical Diagnostic Labs
Agriculture Research Centers
Veterinary Laboratories
Forensic Centers

Breakup by Region:
North America
United States
Asia Pacific
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Affymetrix Inc., Agilent Technologies Inc., Arrayit Corporation, Bio-RAD Laboratories, Inc. Illumina Inc., Laboratory Corporation, Molecular Devices LLC, Raybiotech Inc., Sigma Aldrich Corporation, Thermo Fisher Scientific Inc., etc. ey Questions Answered in This Report:

How has the global array instrument market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global array instruments market?
What is the breakup of the market based on the application?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global array instrument market and who are the key players?
What is the degree of competition in the industry?